Thoracic aortic aneurysm surgery: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Thoracic aortic aneurysm}} {{CMG}}; {{AE}} {{AN}} ==Overview== ==ACC/ AHA Guidelines - Recommendation for Asymptomatic patients with Ascending aortic aneurysm (DO...") |
No edit summary |
||
| Line 12: | Line 12: | ||
|bgcolor="LightGreen" | '''1.''' Asymptomatic patients with degenerative thoracic aneurysm, chronic aortic dissection, intramural hematoma, penetrating atherosclerotic ulcer, mycotic aneurysm, or pseudoaneurysm, who are otherwise suitable candidates and for whom the ascending aorta or aortic sinus diameter is 5.5 cm or greater should be evaluated for surgical repair ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: A]])'' | |bgcolor="LightGreen" | '''1.''' Asymptomatic patients with degenerative thoracic aneurysm, chronic aortic dissection, intramural hematoma, penetrating atherosclerotic ulcer, mycotic aneurysm, or pseudoaneurysm, who are otherwise suitable candidates and for whom the ascending aorta or aortic sinus diameter is 5.5 cm or greater should be evaluated for surgical repair ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: A]])'' | ||
|- | |- | ||
|bgcolor="LightGreen" |'''2.''' Patients with Marfan syndrome or other genetically mediated disorders (vascular Ehlers-Danlos syndrome, Turner syndrome, bicuspid aortic valve, or familial thoracic aortic aneurysm and dissection) should undergo elective operation at smaller diameters (4.0 to 5.0 cm depending on the condition; | |bgcolor="LightGreen" |'''2.''' Patients with Marfan syndrome or other genetically mediated disorders (vascular Ehlers-Danlos syndrome, Turner syndrome, bicuspid aortic valve, or familial thoracic aortic aneurysm and dissection) should undergo elective operation at smaller diameters (4.0 to 5.0 cm depending on the condition; to avoid acute dissection or rupture ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])'' | ||
|- | |- | ||
|bgcolor="LightGreen" |'''3.'''Patients with a growth rate of more than 0.5 cm/y in an aorta that is less than 5.5 cm in diameter should be considered for operation. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])'' | |bgcolor="LightGreen" |'''3.'''Patients with a growth rate of more than 0.5 cm/y in an aorta that is less than 5.5 cm in diameter should be considered for operation. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])'' | ||
| Line 18: | Line 18: | ||
|bgcolor="LightGreen" |'''4.'''Patients undergoing aortic valve repair or replacement and who have an ascending aorta or aortic root of greater than 4.5 cm should be considered for concomitant repair of the aortic root or replacement of the ascending aorta ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence:C]])'' | |bgcolor="LightGreen" |'''4.'''Patients undergoing aortic valve repair or replacement and who have an ascending aorta or aortic root of greater than 4.5 cm should be considered for concomitant repair of the aortic root or replacement of the ascending aorta ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence:C]])'' | ||
|} | |} | ||
{|class="wikitable" | |||
|- | |||
| colspan="1" style="text-align:center; background:LemonChiffon"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIa]] | |||
|- | |||
|bgcolor="LemonChiffon"|'''1.'''Elective aortic replacement is reasonable for patients with Marfan syndrome, other genetic diseases, or bicuspid aortic valves, when the ratio of maximal ascending or aortic root area (πr2) in cm2 divided by the patient's height in meters exceeds 10 ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence:C]])'' | |||
|- | |||
|bgcolor="LemonChiffon"|'''2.'''It is reasonable for patients with Loeys-Dietz syndrome or a confirmed TGFBR1 or TGFBR2 mutation to undergo aortic repair when the aortic diameter reaches 4.2 cm or greater by transesophageal echocardiogram (internal diameter) or 4.4 to 4.6 cm or greater by computed tomographic imaging and/or magnetic resonance imaging (external diameter. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence:C]])'' | |||
|} | |||
==References== | |||
{{reflist|2}} | |||
{{WH}} | |||
{{WS}} | |||
Revision as of 03:35, 9 October 2012
|
Thoracic aortic aneurysm Microchapters |
|
Differentiating Thoracic Aortic Aneurysm from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Special Scenarios |
|
Case Studies |
|
Thoracic aortic aneurysm surgery On the Web |
|
Directions to Hospitals Treating Thoracic aortic aneurysm surgery |
|
Risk calculators and risk factors for Thoracic aortic aneurysm surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]
Overview
ACC/ AHA Guidelines - Recommendation for Asymptomatic patients with Ascending aortic aneurysm (DO NOT EDIT)
| Class I |
| 1. Asymptomatic patients with degenerative thoracic aneurysm, chronic aortic dissection, intramural hematoma, penetrating atherosclerotic ulcer, mycotic aneurysm, or pseudoaneurysm, who are otherwise suitable candidates and for whom the ascending aorta or aortic sinus diameter is 5.5 cm or greater should be evaluated for surgical repair (Level of Evidence: A) |
| 2. Patients with Marfan syndrome or other genetically mediated disorders (vascular Ehlers-Danlos syndrome, Turner syndrome, bicuspid aortic valve, or familial thoracic aortic aneurysm and dissection) should undergo elective operation at smaller diameters (4.0 to 5.0 cm depending on the condition; to avoid acute dissection or rupture (Level of Evidence: C) |
| 3.Patients with a growth rate of more than 0.5 cm/y in an aorta that is less than 5.5 cm in diameter should be considered for operation. (Level of Evidence: C) |
| 4.Patients undergoing aortic valve repair or replacement and who have an ascending aorta or aortic root of greater than 4.5 cm should be considered for concomitant repair of the aortic root or replacement of the ascending aorta (Level of Evidence:C) |
| Class IIa |
| 1.Elective aortic replacement is reasonable for patients with Marfan syndrome, other genetic diseases, or bicuspid aortic valves, when the ratio of maximal ascending or aortic root area (πr2) in cm2 divided by the patient's height in meters exceeds 10 (Level of Evidence:C) |
| 2.It is reasonable for patients with Loeys-Dietz syndrome or a confirmed TGFBR1 or TGFBR2 mutation to undergo aortic repair when the aortic diameter reaches 4.2 cm or greater by transesophageal echocardiogram (internal diameter) or 4.4 to 4.6 cm or greater by computed tomographic imaging and/or magnetic resonance imaging (external diameter. (Level of Evidence:C) |